Press Releases

Press Releases

Filters
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
Viatris Reports Third Quarter Financial Results for 2024
Viatris Announces Third Quarter 2024 Dividend
Viatris Named to Forbes' World's Top Companies for Women 2024 List
Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row
Viatris Announces the Pricing Terms of Maximum Tender Offer
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
Displaying 1 - 10 of 137